华北制药：腺苷钴胺胶囊获得药品注册证书

Core Viewpoint - North China Pharmaceutical (600812.SH) has received approval from the National Medical Products Administration for the registration certificate of Adenosylcobalamin capsules (0.5mg) [1] Group 1: Product Information - Adenosylcobalamin can inhibit abnormal fat synthesis in nerve myelin, blocking the occurrence and development of nerve fiber demyelination [1] - It promotes protein and lipid synthesis, repairing damaged nerves, and lowers abnormal TNFα levels, inhibiting the occurrence of SACD [1] - The product participates in the tricarboxylic acid cycle, promoting the metabolism of three major substances, and maintains normal cell function [1] Group 2: Medical Applications - Adenosylcobalamin is primarily used for the prevention and treatment of vitamin B12 deficiency, especially when dietary intake is insufficient due to conditions like consumptive diseases, hyperthyroidism, pregnancy, and lactation [1] - It is also indicated for megaloblastic anemia and other related conditions [1]